Goel, Heenam
Binkley, Neil
Hans, Didier
Leslie, William D.
Article History
Received: 1 February 2023
Accepted: 10 May 2023
First Online: 22 May 2023
Declarations
:
: Heenam Goel and William Leslie declare no conflict of interest. Neil Binkley declares no conflict of interest for the content of this paper; research funding from Radius; consultant Amgen. Didier Hans: Co-ownership in the TBS patent. Stock options or royalties: Medimaps. Research grants: Amgen, Agnovos.